The Life Chemicals Anticancer Screening Library comprises over 6,300 novel drug-like screening compounds with potential anti-tumor activity, targeting various cancer types.
The GPCR Library comprises over 8,000 novel and scaffold-based compounds designed using a series of GPCR-relevant scaffolds that mimic the beta-turn motif of endogenous peptide ligands.
The design and discovery of novel chemical entities with profound antiviral activity and improved safety profiles require access to high-quality screening compounds that could deliver a meaningful starting point for further development.
Swiss Prot Protein Targets and PDB X Ray Structure Search: ACE2, PLpro, 3CLP Training Sets ChEMBL 25, PubMed, Current Patent Literature (CAS, Integrity)
ChemBridge chemists have produced a diverse collection of novel, synthetic macrocycle scaffolds, including scaffolds incorporating proprietary fragments. Primary ring sizes range from 11 to 27 atoms and MW weight up to 800. The Macrocycle Library represents more than 13,000 synthetic, macrocyclic compounds following its expansion in 2018.
Life Chemicals offers its original stock collection of 140,000 novel small-molecule screening compounds based on 1,300 novel molecular scaffolds (including more than 500 premium ones) for medicinal chemistry and drug discovery screening projects.
Life Chemicals has designed its dedicated Antibacterial Screening Library of over 11,100 drug-like screening compounds with potential antibacterial activity as an excellent starting point for high throughput screening (HTS) and high content screening (HCS
For hit finding across different targets, against novel targets, or for the discovery of new chemical series against existing targets, ChemBridge offers up to 150,000 DIVERSet Library compounds in economical, pre-plated format.